The PET packaging market in pharmaceuticals is witnessing robust growth, driven by rising demand for lightweight, durable, and sustainable packaging solutions. As the industry aims for sterility, safety, and cost-effectiveness, PET (Polyethylene Terephthalate) emerges as a game-changer—perfect for syrups, vitamin supplements, and liquid medications. With North America dominating the market in 2024 and Asia Pacific poised for rapid expansion, the global landscape is evolving at a significant pace.
North America held the largest revenue share at 38% in 2024, thanks to advanced healthcare systems and strong regulatory frameworks.
Asia Pacific is projected as the fastest-growing region between 2025 and 2034, fueled by increasing pharmaceutical production and demand for affordable packaging solutions.
By packaging type, PET Bottles led with a 60% revenue share in 2024, while blister packs are expected to register impressive CAGR growth.
In terms of drug forms, solid dosage forms accounted for 55% of revenue in 2024, but ophthalmic and nasal solutions are projected to grow rapidly in the coming years.
About: Amcor is a global leader in developing and producing responsible packaging solutions. With operations in over 40 countries, it emphasizes innovation and sustainability.
Products: PET bottles, blister packs, pharmaceutical pouches, and sterile medical packaging.
Market Cap: Approx. $15.2 billion (2025).
About: Gerresheimer AG, based in Germany, specializes in manufacturing pharmaceutical packaging and drug delivery devices.
Products: PET bottles, glass containers, prefillable syringes, and inhalers.
Market Cap: Approx. $4.3 billion (2025).
About: CCL Industries is a Canadian packaging giant and the world’s largest label company, serving healthcare, consumer goods, and specialty markets.
Products: Pharmaceutical labels, PET-based packaging, and security solutions.
Market Cap: Approx. $12.8 billion (2025).
About: Known for sustainable packaging innovations, Graham Packaging focuses on consumer and pharmaceutical markets with advanced PET designs.
Products: PET bottles, vials, and customized container solutions.
Market Cap: Privately held; estimated annual revenue ~$2.8 billion.
About: A diversified global packaging company, Sonoco provides consumer, industrial, healthcare, and protective packaging solutions.
Products: PET containers, healthcare packaging, and engineered materials.
Market Cap: Approx. $7.1 billion (2025).
About: A leading manufacturer of innovative delivery systems and components for injectable drugs.
Products: PET-based primary packaging, stoppers, seals, and prefilled syringe components.
Market Cap: Approx. $26.5 billion (2025).
About: Huhtamaki is a Finnish global leader in sustainable packaging solutions for food and pharmaceuticals.
Products: PET bottles, blister packs, and protective packaging solutions.
Market Cap: Approx. $4.6 billion (2025).
About: An emerging player in India’s pharmaceutical packaging industry, focusing on PET and HDPE solutions.
Products: PET bottles, tablet containers, and dropper bottles.
Market Cap: Privately held; estimated revenue ~$15 million.
About: AG Poly Packs is an Indian company specializing in high-quality plastic packaging for pharmaceuticals and personal care.
Products: PET containers, spray bottles, and customized designs.
Market Cap: Privately held; estimated revenue ~$10 million.
Invest in Our Premium Strategic Solution: https://www.towardspackaging.com/price/5696
About: Goldmine Polymers Industries caters to the pharmaceutical and cosmetic packaging market in India with a focus on PET innovations.
Products: PET bottles, jars, and pharma-grade packaging solutions.
Market Cap: Privately held; estimated revenue ~$8 million.
The PET packaging market in pharmaceuticals will continue to expand as manufacturers prioritize eco-friendly, lightweight, and tamper-evident solutions. Innovations in barrier technologies and recyclability will also play crucial roles in shaping market dynamics between 2025 and 2034.
Q1: Why is PET preferred for pharmaceutical packaging?
A: PET is lightweight, durable, offers excellent barrier properties, and ensures product sterility, making it ideal for pharmaceuticals.
Q2: Which region leads the PET packaging market?
A: North America held the largest share in 2024, while Asia Pacific is expected to grow fastest through 2034.
Q3: What drug forms are packaged in PET most commonly?
A: Solid dosage forms like tablets and capsules dominate, but liquid medications and ophthalmic solutions are growing segments.
Q4: What is the CAGR of the PET blister packs segment?
A: Blister packs are expected to register a significant CAGR between 2025 and 2034 due to demand for unit-dose packaging.
Q5: Who are the top global players in the PET pharmaceutical packaging market?
A: Key companies include Amcor, Gerresheimer, CCL Industries, Graham Packaging, and West Pharmaceutical Services.
Source : https://www.towardspackaging.com/insights/pet-packaging-in-pharmaceutical-market-sizing
The global food packaging market is on an impressive growth trajectory, projected to reach USD…
The flexible packaging market is expected to witness significant growth from USD 323.25 billion in…
The global electrostatic discharge (ESD) packaging market is projected to grow significantly, from USD 2.38…
The refillable airless packaging system market is experiencing significant growth and is set to generate…
The tortilla wrap packaging market is on the verge of a significant revenue surge, expected…
The global corrugated bulk bin market is witnessing impressive growth, projected to increase from USD…